Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 1
1946 1
1955 1
1957 1
1962 5
1963 8
1964 4
1965 6
1966 6
1967 11
1968 6
1969 7
1970 4
1971 4
1972 9
1973 13
1974 5
1975 5
1976 13
1977 13
1978 13
1979 15
1980 24
1981 17
1982 13
1983 16
1984 23
1985 27
1986 18
1987 22
1988 18
1989 19
1990 20
1991 31
1992 36
1993 19
1994 18
1995 23
1996 15
1997 16
1998 19
1999 18
2000 28
2001 37
2002 45
2003 43
2004 61
2005 87
2006 91
2007 104
2008 98
2009 105
2010 147
2011 138
2012 175
2013 207
2014 206
2015 228
2016 222
2017 240
2018 258
2019 260
2020 309
2021 361
2022 373
2023 376
2024 428
2025 455
2026 59

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,114 results

Results by year

Filters applied: . Clear all
Page 1
Trained Innate Immunity.
Pal S, Rafiq Z, Kumari R, Al Aiyan A, Al-Ramadi B, Kishore U, Ponnachan P. Pal S, et al. Adv Exp Med Biol. 2025;1476:275-296. doi: 10.1007/978-3-031-85340-1_11. Adv Exp Med Biol. 2025. PMID: 40622547 Review.
Microbiome Modulation for the Treatment of Solid Neoplasms.
Barragan-Carrillo R, Zengin ZB, Pal SK. Barragan-Carrillo R, et al. Among authors: pal sk. J Clin Oncol. 2025 Aug 20;43(24):2734-2738. doi: 10.1200/JCO-25-00374. Epub 2025 Jul 11. J Clin Oncol. 2025. PMID: 40644647 Free PMC article. Review.
AXL signaling in cancer: from molecular insights to targeted therapies.
Yadav M, Sharma A, Patne K, Tabasum S, Suryavanshi J, Rawat L, Machaalani M, Eid M, Singh RP, Choueiri TK, Pal S, Sabarwal A. Yadav M, et al. Among authors: pal s. Signal Transduct Target Ther. 2025 Feb 10;10(1):37. doi: 10.1038/s41392-024-02121-7. Signal Transduct Target Ther. 2025. PMID: 39924521 Free PMC article. Review.
Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinoma.
Rini BI, Albiges L, Tang X, Koeppen H, Bex A, Suárez C, Uzzo R, Hamidi H, Assaf ZJ, Dubey S, Goluboff ET, Carter C, Pal SK, Banchereau RF, Xu W, Huseni MA. Rini BI, et al. Among authors: pal sk. Ann Oncol. 2025 Dec;36(12):1525-1534. doi: 10.1016/j.annonc.2025.08.007. Epub 2025 Aug 28. Ann Oncol. 2025. PMID: 40885527 Free article. Clinical Trial.
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma.
Salgia NJ, Khan A, Aubrecht WM, Twoey GC, Chow J, Attwood K, Yu H, Chiello JL, Hansen N, Wasik BJ, Mercier BD, Ebrahimi H, Meza L, Maguire O, Mastri M, Whalen C, Minderman H, Pirrotte P, Byron S, Repasky EA, Singh PK, Bshara W, Wang J, McGray AJR, Abrams SI, Xu B, Eng KH, Long MD, Pal SK, Kauffman EC, Muhitch JB. Salgia NJ, et al. Among authors: pal sk. Cancer Cell. 2025 Nov 10;43(11):2014-2033.e9. doi: 10.1016/j.ccell.2025.07.010. Epub 2025 Aug 7. Cancer Cell. 2025. PMID: 40780212 Free PMC article.
Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells.
Madan E, Palma AM, Vudatha V, Kumar A, Bhoopathi P, Wilhelm J, Bernas T, Martin PC, Bilolikar G, Gogna A, Peixoto ML, Dreier I, Araujo TF, Garre E, Gustafsson A, Dorayappan KDP, Mamidi N, Sun Z, Yekelchyk M, Accardi D, Olsen AL, Lin L, Titelman AA, Bianchi M, Jessmon P, Farid EA, Pradhan AK, Neufeld L, Yeini E, Maji S, Pelham CJ, Kim H, Oh D, Rolfsnes HO, Marques RC, Lu A, Nagane M, Chaudhary S, Gupta K, Gogna KC, Bigio A, Bhoopathi K, Mannangatti P, Achary KG, Akhtar J, Belião S, Das S, Correia I, da Silva CL, Fialho AM, Poellmann MJ, Javius-Jones K, Hawkridge AM, Pal S, Shree KS, Rakha EA, Khurana S, Xiao G, Zhang D, Rijal A, Lyons C, Grossman SR, Turner DP, Pillappa R, Prakash K, Gupta G, Robinson GLWG, Koblinski J, Wang H, Singh G, Singh S, Rayamajhi S, Bacolod MD, Richards H, Sayeed S, Klein KP, Chelmow D, Satchi-Fainaro R, Selvendiran K, Connolly D, Thorsen FA, Bjerkvig R, Nephew KP, Idowu MO, Kühnel MP, Moskaluk C, Hong S, Redmond WL, Landberg G, Lopez-Beltran A, Poklepovic AS, Sanyal A, Fisher PB, Church GM, Menon U, Drapkin R, Godwin AK, Luo Y, Ackermann M, Tzankov A, Mertz KD, Jonigk D, Tsung A, Sidransky D, Trevino J, Saavedra AP, Winn R, Won KJ, Moreno E, Gogna … See abstract for full author list ➔ Madan E, et al. Among authors: pal s. Nat Biotechnol. 2025 Nov;43(11):1833-1847. doi: 10.1038/s41587-024-02453-3. Epub 2024 Dec 9. Nat Biotechnol. 2025. PMID: 39653752
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types.
Bex A, Jewett M, Lewis B, Abel EJ, Albiges L, Berg SA, Bratslavsky G, Braun D, Brugarolas J, Choueiri TK, Finelli A, George D, Haas NB, Hakimi AA, Hammers H, Hirsch M, Jonasch E, Kapur P, Linehan WM, Master V, McGregor B, McKay RR, Mehra R, Pal S, Poteat S, Powles TB, Rossi SH, Shapiro DD, Signoretti S, Singer EA, Stravin C, Tannir N, Vaishampayan U, Xu W, Stewart GD. Bex A, et al. Among authors: pal s. Eur Urol. 2025 Apr;87(4):385-389. doi: 10.1016/j.eururo.2025.01.007. Epub 2025 Jan 23. Eur Urol. 2025. PMID: 39855942
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.
Rendo V, Lee EQ, Bossi C, Khuu N, Rudek MA, Pal S, Azazmeh N, Rashid R, Lin JR, Cusick M, Reynolds ARN, Fassinou ACR, Ayoub G, Malinowski S, Lapinskas E, Pisano W, Jeang J, Stopka SA, Regan MS, Spetz J, Desai A, Lieberman F, Palanichamy K, Fisher JD, Pelton K, Huang RY, Sarosiek KA, Nabors LB, Holdhoff M, Danda N, Strowd R, Desideri S, Walbert T, Ye X, Chakravarti A, Sorger PK, Santagata S, Agar NYR, Grossman SA, Alexander BM, Wen PY, Ligon KL, Beroukhim R. Rendo V, et al. Among authors: pal s. Sci Transl Med. 2025 Feb 19;17(786):eadn6274. doi: 10.1126/scitranslmed.adn6274. Epub 2025 Feb 19. Sci Transl Med. 2025. PMID: 39970230 Free PMC article. Clinical Trial.
S1PR1 regulates lymphatic valve development and tertiary lymphoid organ formation in the ileum.
Geng X, Chen L, Ahmed Z, Formigari GP, Ho YC, Del Gaudio I, Datilo MN, Azartash-Namin ZJ, Heron C, Shan X, Keshari RS, Pal S, Chen H, Lupu F, Xia L, Randolph GJ, Zawieja SD, Camerer E, Davis MJ, Srinivasan RS. Geng X, et al. Among authors: pal s. J Exp Med. 2025 Sep 1;222(9):e20241799. doi: 10.1084/jem.20241799. Epub 2025 Jun 24. J Exp Med. 2025. PMID: 40553105 Free PMC article.
5,114 results